Prognostic and Predictive Signatures in Breast Cancer Using Surrogate Tissue
In this talk I will present an overview of how genomics and bioinformatics have been used to develop gene signatures for clinical end-points in breast cancer primarily using primary tumor tissue. I will then describe our new methods focused on the same end-points using only surrogate tissue which can be obtained in a minimally invasive manner.
- Prognostic and predictive gene signatures.
- Primary tumor versus microenvironment versus patient systemic response.
- Single cell sequencing, immune profiles
- Molecular interactions between the primary tumor and surrogate tissue
Wednesday, February 21, 2018
16:00 - 17:00
Loyola Jesuit Hall & Conference Centre
7141 Sherbrooke St W.,
Loyola Jesuit Hall & Conference Centre,
Room L-RF 120
Michael Hallett, PhD,
Department of Biology,
Centre for Structural and Functional Genomics,
Centre for Applied Synthetic Biology,
Everyone is welcome. This event is free of charge. No registration required.